Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Armata Pharmaceuticals, Inc. | tv487129_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Armata Pharmaceuticals, Inc. | tv487129_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Armata Pharmaceuticals, Inc. | tv487129_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Armata Pharmaceuticals, Inc. | tv487129_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Armata Pharmaceuticals, Inc. | tv487129_ex21-1.htm |
| 10-K - 10-K - Armata Pharmaceuticals, Inc. | tv487129_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statements (Form S-1 Nos. 333-213421, 333-217169 and 333-217680) of AmpliPhi Biosciences Corporation, |
| (2) | Registration Statement (Form S-3 No. 333-210974) of AmpliPhi Biosciences Corporation, |
| (3) | Registration Statement (Form S-8 No. 333-203455) pertaining to the 2012 Stock Incentive Plan and 2013 Stock Incentive Plan, |
| (4) | Registration Statement (Form S-8 No. 333-221564) pertaining to the AmpliPhi Biosciences Corporation 2016 Equity Incentive Plan, and |
| (5) | Registration Statements (Form S-8 Nos. 333-212183 and 333-217563) pertaining to the AmpliPhi Biosciences Corporation 2016 Employee Stock Purchase Plan and AmpliPhi Biosciences Corporation 2016 Equity Incentive Plan; |
of our report dated March 14, 2018, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation included in this Annual Report (Form 10-K) of AmpliPhi Biosciences Corporation for the year ended December 31, 2017.
| /s/ Ernst & Young LLP | |
| San Diego, California | |
| March 14, 2018 |